These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11344167)

  • 21. Purification of nuclear proteins that bind to cisplatin-damaged DNA. Identity with high mobility group proteins 1 and 2.
    Hughes EN; Engelsberg BN; Billings PC
    J Biol Chem; 1992 Jul; 267(19):13520-7. PubMed ID: 1618852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of cDNA clones encoding the Drosophila homolog of the HMG-box SSRP family that recognizes specific DNA structures.
    Bruhn SL; Housman DE; Lippard SJ
    Nucleic Acids Res; 1993 Apr; 21(7):1643-6. PubMed ID: 8479916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins.
    Kaspárková J; Brabec V
    Biochemistry; 1995 Sep; 34(38):12379-87. PubMed ID: 7547982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional roles of the DNA-binding HMGB domain in the histone chaperone FACT in nucleosome reorganization.
    McCullough LL; Connell Z; Xin H; Studitsky VM; Feofanov AV; Valieva ME; Formosa T
    J Biol Chem; 2018 Apr; 293(16):6121-6133. PubMed ID: 29514976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.
    Huang JC; Zamble DB; Reardon JT; Lippard SJ; Sancar A
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10394-8. PubMed ID: 7937961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repair of cisplatin--DNA adducts by the mammalian excision nuclease.
    Zamble DB; Mu D; Reardon JT; Sancar A; Lippard SJ
    Biochemistry; 1996 Aug; 35(31):10004-13. PubMed ID: 8756462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA-interactions and nuclear localisation of the chromosomal HMG domain protein SSRP1 from maize.
    Röttgers K; Krohn NM; Lichota J; Stemmer C; Merkle T; Grasser KD
    Plant J; 2000 Aug; 23(3):395-405. PubMed ID: 10929132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins.
    Kane SA; Lippard SJ
    Biochemistry; 1996 Feb; 35(7):2180-8. PubMed ID: 8652559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A bipartite yeast SSRP1 analog comprised of Pob3 and Nhp6 proteins modulates transcription.
    Brewster NK; Johnston GC; Singer RA
    Mol Cell Biol; 2001 May; 21(10):3491-502. PubMed ID: 11313475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of the binding region of high mobility group protein 2 to cisplatin-damaged DNA.
    Lawrence DL; Engelsberg BN; Farid RS; Hughes EN; Billings PC
    J Biol Chem; 1993 Nov; 268(32):23940-5. PubMed ID: 8226934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SSRP1 Cooperates with PARP and XRCC1 to Facilitate Single-Strand DNA Break Repair by Chromatin Priming.
    Gao Y; Li C; Wei L; Teng Y; Nakajima S; Chen X; Xu J; Leger B; Ma H; Spagnol ST; Wan Y; Dahl KN; Liu Y; Levine AS; Lan L
    Cancer Res; 2017 May; 77(10):2674-2685. PubMed ID: 28416484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HMG domain proteins induce sharp bends in cisplatin-modified DNA.
    Chow CS; Whitehead JP; Lippard SJ
    Biochemistry; 1994 Dec; 33(50):15124-30. PubMed ID: 7999772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intercalating residues determine the mode of HMG1 domains A and B binding to cisplatin-modified DNA.
    He Q; Ohndorf UM; Lippard SJ
    Biochemistry; 2000 Nov; 39(47):14426-35. PubMed ID: 11087395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin.
    Pil PM; Lippard SJ
    Science; 1992 Apr; 256(5054):234-7. PubMed ID: 1566071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solution structure of the HMG-box domain in the SSRP1 subunit of FACT.
    Kasai N; Tsunaka Y; Ohki I; Hirose S; Morikawa K; Tate S
    J Biomol NMR; 2005 May; 32(1):83-8. PubMed ID: 16041486
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential binding of HMG1, HMG2, and a single HMG box to cisplatin-damaged DNA.
    Farid RS; Bianchi ME; Falciola L; Engelsberg BN; Billings PC
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):532-9. PubMed ID: 8975778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of Ixr1, a yeast HMG-domain protein, to cisplatin-DNA adducts in vitro and in vivo.
    McA'Nulty MM; Whitehead JP; Lippard SJ
    Biochemistry; 1996 May; 35(19):6089-99. PubMed ID: 8634251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylated intrinsically disordered region of FACT masks its nucleosomal DNA binding elements.
    Tsunaka Y; Toga J; Yamaguchi H; Tate S; Hirose S; Morikawa K
    J Biol Chem; 2009 Sep; 284(36):24610-21. PubMed ID: 19605348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The major chromatin protein histone H1 binds preferentially to cis-platinum-damaged DNA.
    Yaneva J; Leuba SH; van Holde K; Zlatanova J
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13448-51. PubMed ID: 9391045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human replication protein A preferentially binds cisplatin-damaged duplex DNA in vitro.
    Patrick SM; Turchi JJ
    Biochemistry; 1998 Jun; 37(24):8808-15. PubMed ID: 9628743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.